272 related articles for article (PubMed ID: 32599083)
21. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Shamir ER; Chen YY; Krings G
Mod Pathol; 2020 Jun; 33(6):1078-1091. PubMed ID: 31907376
[TBL] [Abstract][Full Text] [Related]
22. Expression of N-Terminal-Deficient E-Cadherin Protein in Invasive Lobular Carcinoma of the Breast.
Yasui H; Kawata T; Muramatsu K; Kakuda Y; Oishi T; Norose T; Notsu A; Nishimura S; Fukuoka J; Sugino T
Am J Surg Pathol; 2022 Mar; 46(3):383-391. PubMed ID: 34653059
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
[TBL] [Abstract][Full Text] [Related]
24. Salivary Duct Carcinoma With Rhabdoid Features-No or Aberrant Expression of E-cadherin and Genetic Changes in CDH1: Immunohistochemical and Genetic Analyses of 17 Cases.
Kusafuka K; Yamada H; Ishino K; Maeda M; Yamanegi K; Baba S; Ohuchi T; Inagaki H; Yamamoto H; Iwasaki T; Tsuchiya C; Sugimura H; Suzuki M
Am J Surg Pathol; 2021 Apr; 45(4):439-449. PubMed ID: 33538422
[TBL] [Abstract][Full Text] [Related]
25. Loss of E-cadherin Induces IGF1R Activation and Reveals a Targetable Pathway in Invasive Lobular Breast Carcinoma.
Elangovan A; Hooda J; Savariau L; Puthanmadhomnarayanan S; Yates ME; Chen J; Brown DD; McAuliffe PF; Oesterreich S; Atkinson JM; Lee AV
Mol Cancer Res; 2022 Sep; 20(9):1405-1419. PubMed ID: 35665642
[TBL] [Abstract][Full Text] [Related]
26. Mixed ductal-lobular carcinoma: an analysis of CDH1 DNA copy number variation and mutation.
Tang X; Nakanishi Y; Kobayashi H; Nishimaki H; Kusumi Y; Miyagi Y; Masuda S
Breast Cancer; 2021 Nov; 28(6):1318-1327. PubMed ID: 34185256
[TBL] [Abstract][Full Text] [Related]
27. Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: Differences in clinicopathological and immunohistochemical features.
Ilic IR; Djordjevic NP; Randjelovic PJ; Stojanovic NM; Radulovic NS; Ilic RS
J BUON; 2016; 21(5):1113-1120. PubMed ID: 27837612
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
[TBL] [Abstract][Full Text] [Related]
29. E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.
Nurismah MI; Noriah O; Suryati MY; Sharifah NA
Asian Pac J Cancer Prev; 2008; 9(4):699-702. PubMed ID: 19256762
[TBL] [Abstract][Full Text] [Related]
30. Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findings.
El Sharouni MA; Postma EL; van Diest PJ
Virchows Arch; 2017 Dec; 471(6):707-712. PubMed ID: 28779344
[TBL] [Abstract][Full Text] [Related]
31. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study.
Rakha EA; Teoh TK; Lee AH; Nolan CC; Ellis IO; Green AR
Histopathology; 2013 Apr; 62(5):695-701. PubMed ID: 23347178
[TBL] [Abstract][Full Text] [Related]
32. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
33. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
Droufakou S; Deshmane V; Roylance R; Hanby A; Tomlinson I; Hart IR
Int J Cancer; 2001 May; 92(3):404-8. PubMed ID: 11291078
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.
Vos CB; Cleton-Jansen AM; Berx G; de Leeuw WJ; ter Haar NT; van Roy F; Cornelisse CJ; Peterse JL; van de Vijver MJ
Br J Cancer; 1997; 76(9):1131-3. PubMed ID: 9365159
[TBL] [Abstract][Full Text] [Related]
35. [Expression pattern of E-cadherin and p120-catenin in infiltrating lobular carcinoma and ductal carcinoma of the breast and its significance].
Li L; Bi XF; Xu X; Liu XY; Shen GH; Guo L; Yuan YL; Wang F; Wang MR; Yang HY
Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):273-7. PubMed ID: 20510078
[TBL] [Abstract][Full Text] [Related]
36. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
37. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
Van Baelen K; Geukens T; Maetens M; Tjan-Heijnen V; Lord CJ; Linn S; Bidard FC; Richard F; Yang WW; Steele RE; Pettitt SJ; Van Ongeval C; De Schepper M; Isnaldi E; Nevelsteen I; Smeets A; Punie K; Voorwerk L; Wildiers H; Floris G; Vincent-Salomon A; Derksen PWB; Neven P; Senkus E; Sawyer E; Kok M; Desmedt C
Ann Oncol; 2022 Aug; 33(8):769-785. PubMed ID: 35605746
[TBL] [Abstract][Full Text] [Related]
38. [Expression of E-cadherin, p120catenin and 34βE12 in invasive lobular carcinoma of breast and their roles in diagnosis].
Yang GZ; Zhang XL; Li J; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):741-4. PubMed ID: 22336156
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
Pramod N; Nigam A; Basree M; Mawalkar R; Mehra S; Shinde N; Tozbikian G; Williams N; Majumder S; Ramaswamy B
Oncologist; 2021 Jun; 26(6):e943-e953. PubMed ID: 33641217
[TBL] [Abstract][Full Text] [Related]
40. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
